- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02279836
Single Arm Post-marketing Study of SC20 Colonoscope (SC20 Scope)
February 3, 2015 updated by: Invendo Medical GmbH
Open Label, Multi-center, Single Arm Post-marketing Study of SC20 Colonoscope and Colonoscopy System for Colonoscopy in Male and Female Patients >18 Years Old
The objective of the study is to gather post-market data regarding the performance of the invendo SC20 colonoscope in a real-world US population.
Study Overview
Detailed Description
The objective of the study is to expand data collection and product exposure in a controlled clinical setting and gather data regarding the performance of the Invendo SC20 colonoscope in a real-world US population. The objective of the study is to specifically monitor three points:
- The diagnostic performance of the device including polyp and adenoma detection rates;
- The therapeutic performance of the device (the ability of the physician to remove/biopsy identified lesions);
- Performance of the device in a typical colonoscopy population, including patients with underlying inflammatory bowel disease (IBD), previous pelvic surgery or irradiation, obesity, diverticular disease, and previous colorectal surgery, as they present in the study population (see below C.).
Study Type
Interventional
Enrollment (Actual)
2
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- Bellevue Hospital Center
-
New York, New York, United States, 10032
- New York Presbyterian Columbia University Medical Center
-
New York, New York, United States, 10016
- NYU Langone Medical Center Ambulatory care
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any indication for colonoscopy
- Willing to give informed consent
- Willing to consume 2-4 liters of bowel prep
Exclusion Criteria:
- An age younger than 18 years
- Congestive heart failure
- Renal insufficiency
- Intestinal obstruction
- Any acute life-threatening condition (in the opinion of the investigator)
- Current pregnancy
- Abdominal surgery in the past 6 months
- Bleeding disorders
- Inability to provide informed consent
- Any other contraindication to colonoscopy (e.g. fulminant colitis or acute diverticulitis)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Single arm post-marketing Study
SC20 Colonoscope and Colonoscopy System For Colonoscopy
|
Single Arm Post-Marketing Study of SC20 Colonoscope
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. Cecal intubation rates (visualization of the cecum by notation of landmarks and photo documentation of landmarks in every procedure)
Time Frame: average 6 to 12 months
|
average 6 to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
2. Detection of polyps, adenomas and other lesions in all individuals
Time Frame: average 6 to 12 months
|
average 6 to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adam Goodman, MD, NYU Langone Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Anticipated)
October 1, 2015
Study Completion (Anticipated)
January 1, 2016
Study Registration Dates
First Submitted
October 28, 2014
First Submitted That Met QC Criteria
October 29, 2014
First Posted (Estimate)
October 31, 2014
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
February 3, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- Invendo s14-01040
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gentle Colonoscopy
-
Borland-Groover ClinicValley Medical Products, LLC is paying for the study and is the sponsor....CompletedColonoscopy | Screening Colonoscopy | Surveillance ColonoscopyUnited States
-
Josue AliagaCompleted
-
Endostart srlCompleted
-
Hospital Central Norte PEMEXRecruitingPerformance of Colonoscopy | Tolerance of ColonoscopyMexico
-
VA Office of Research and DevelopmentVA Palo Alto Health Care System; VA Northern California Health Care SystemCompletedWater Exchange Colonoscopy | Unsedated Colonoscopy | Cap | Colonoscopy PainUnited States
-
Rambam Health Care CampusUnknownInadequate Preparation for Colonoscopy; Personalized Colonoscopy PreparationIsrael
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Valduce HospitalCompletedUnsedated Colonoscopy | Warm Water | CO2 ColonoscopyItaly
-
Kartal Kosuyolu Yuksek Ihtisas Education and Research...UnknownColonoscopy | Complete Colonoscopy | Cecum Intubation Time | İleum Intubation TimeTurkey
-
Daewoong Pharmaceutical Co. LTD.Not yet recruiting
Clinical Trials on SC20 Colonoscope
-
Sorlandet Hospital HFCompletedColorectal Cancer | AdenomasNorway
-
Nanfang Hospital of Southern Medical UniversityUnknownUlcerative Colitis in Remission | Prospective StudyChina
-
Assiut UniversityNot yet recruitingRole of Ileoscopy in Diagnosis of Colitis
-
Institut Paoli-CalmettesCompletedColorectal AdenomaFrance
-
Medical College of WisconsinWithdrawnColonic NeoplasmsUnited States
-
Norwegian Department of Health and Social AffairsSykehuset TelemarkCompletedCarcinoma | Adenoma | Colitis | Functional Colonic DiseaseNorway
-
Michael WallaceOlympus America, Inc.CompletedPost-endoscopic Mucosal Resection of Colon PolypsUnited States
-
Loma Linda UniversityWithdrawnColonic PolypsUnited States
-
VA Palo Alto Health Care SystemKansas City Veteran Affairs Medical CenterCompletedColorectal Neoplasms | Colorectal Cancer | Colonic PolypsUnited States